The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ODALIE Study, a retrospective analysis of a real-life cohort of patients with de novo advanced high grade epithelial ovarian cancer treated with a first-line platinum- and taxane-based chemotherapy combined with bevacizumab.
 
Sarah Lagarde Bétrian
No Relationships to Disclose
 
Frederique Penault Llorca
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Illumina; Myriad Genetics
Research Funding - Illumina
Travel, Accommodations, Expenses - AstraZeneca/Merck
 
Patricia Pautier
Consulting or Advisory Role - AstraZeneca (Inst); MSD Oncology (Inst); MSD vaccin (Inst); Onxeo (Inst); PharmaMar (Inst)
Research Funding - Onxeo (Inst); PharmaMar (Inst)
Expert Testimony - Clovis Oncology (Inst); Onxeo (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology; OSE Immunotherapeutics; Roche
 
Florence Joly
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; BMS; GlaxoSmithKline; Ipsen; Janssen
 
Isabelle Laure Ray-Coquard
Honoraria - Abbvie; Advaxis; AGENUS; Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; DECIPHERA; Genmab; GlaxoSmithKline; Macrogenics; MERSANA; MSD Oncology; Novartis; OxOnc; Pfizer; PharmaMar; Roche; Seagen; Sutro Biopharma; Tesaro
Consulting or Advisory Role - Abbvie; AGENUS; AstraZeneca; BMS; Bristol-Myers Squibb; Clovis Oncology; Deciphera; Genmab; GlaxoSmithKline; Macrogenics; Mersana; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Roche; Seagen; Tesaro
Research Funding - BMS; MSD Oncology; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; BMS; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; Belgium health authorities; French National Cancer Institute (INCA); GERMAN health authorities; ITALIAN HEALTH AUTORITIES
 
Hélène Costaz
No Relationships to Disclose
 
Baptiste Sauterey
No Relationships to Disclose
 
Anne Floquet
Consulting or Advisory Role - Clovis Oncology; GlaxoSmithKline
Travel, Accommodations, Expenses - ASCO; EGSO; ESMO; GlaxoSmithKline; MSD; PharmaMar
Other Relationship - AstraZeneca/MedImmune/GlaxoSmithKline
 
Thibault De La Motte Rouge
Honoraria - AstraZeneca; Mylan; Pfizer; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; MSD Oncology (Inst); Mylan; Pfizer; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Sophie Gourgou
Consulting or Advisory Role - Celgene; Roche
 
Frédéric Marchal
No Relationships to Disclose
 
Cecile Guillemet
No Relationships to Disclose
 
Thierry Petit
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Novartis; Pfizer; Pierre Fabre; Seagen
Travel, Accommodations, Expenses - Novartis; Novartis; Novartis; Pfizer; Pfizer; Pierre Fabre
 
Roman Rouzier
No Relationships to Disclose
 
Gaetane Simon
No Relationships to Disclose
 
Laurence Gladieff
Consulting or Advisory Role - AstraZeneca; Clovis Oncology (Inst); GlaxoSmithKline; MSD Oncology (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar